Germany set to approve $3.5 billion defence package with Airbus and others, Bloomberg News reports
Nov 8 (Reuters) – Germany is set to approve defence equipment purchases worth more than $3.47 billion, including…
UK sends defence equipment to help Belgium deal with disruptive drones
LONDON, Nov 9 (Reuters) – Britain is sending experts and equipment to Belgium to help it combat disruptive…
Three die as heavy seas batter Spanish island of Tenerife
MADRID, Nov 9 (Reuters) – Three people died and 15 were injured on Saturday as rough seas battered…
Hungary’s waiver from US sanctions on Russia energy is indefinite, minister says
Item 1 of 2 U.S. President Donald Trump hosts a bilateral lunch with Hungary’s Prime Minister Viktor Orban…
China suspends ban on exports of gallium, germanium, antimony to US
BEIJING, Nov 9 (Reuters) – China has suspended a ban on approving exports of “dual-use items” related to…
Ukrainian drones hit electricity substation in northern Russia, governor says
MOSCOW, Nov 8 (Reuters) – Three Ukrainian drones hit an electricity substation in the northern Russian region of…
Russia attacks Ukraine energy facilities, kills three people
Item 1 of 2 Apartment buildings hit during a Russian drone strike, amid Russia’s attack on Ukraine, in…
Taiwan vice president makes rare trip to Europe for parliament speech
TAIPEI, Nov 8 (Reuters) – Taiwan Vice President Hsiao Bi-khim made an unusual visit to Belgium on Friday…
Lukoil operations face fallout from Trump sanctions, Gunvor drops bid
Gunvor withdrew its bid for Lukoil’s foreign assets on ThursdayMoldova requests exemption from US sanctionsBulgarian parliament passes law…
Nearly 100 people abducted or disappeared in Syria since January, says UN
GENEVA, Nov 7 (Reuters) – Nearly 100 people have been recorded as abducted or disappeared in Syria since…
James Watson, co-discoverer of DNA’s double helix, dead at 97
Nov 7 (Reuters) – James D. Watson, the brilliant but controversial American biologist whose 1953 discovery of the…
Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle
Pfizer’s latest bid could spell end of bidding war with NovoMetsera’s drugs projected to reach $5 billion in…